Clinical Trials Logo

Lower Urinary Tract Symptoms clinical trials

View clinical trials related to Lower Urinary Tract Symptoms.

Filter by:

NCT ID: NCT01021332 Completed - Clinical trials for Benign Prostatic Hyperplasia

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms

Neptune II
Start date: April 26, 2010
Phase: Phase 3
Study type: Interventional

Clinical study to examine the safety, tolerability and efficacy of long-term combination therapy of tamsulosin and solifenacin in the treatment of males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) with a substantial storage component.

NCT ID: NCT01018511 Completed - Clinical trials for Benign Prostatic Hyperplasia

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

Neptune
Start date: January 2010
Phase: Phase 3
Study type: Interventional

Clinical study to examine the efficacy, safety and tolerability of combination therapy of tamsulosin hydrochloride and solifenacin succinate compared to monotherapy of tamsulosin hydrochloride in the treatment of males with LUTS associated with BPH with a substantial storage component.

NCT ID: NCT01002664 Completed - Clinical trials for Benign Prostatic Hyperplasia

Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

MCS_LUTS
Start date: May 2010
Phase: Phase 3
Study type: Interventional

The hypothesis of the study is to examine whether MCS-2 is safe and effective in the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

NCT ID: NCT01002417 Completed - Clinical trials for Benign Prostatic Hyperplasia

MCS in the Treatment of Lower Urinary Tract Symptoms

MCS_LUTS
Start date: July 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The hypothesis of the study is to examine whether MCS-2 is safe and effective in the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

NCT ID: NCT01002274 Completed - Clinical trials for Benign Prostatic Hyperplasia

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

MCS-2-TWN-c
Start date: August 2010
Phase: Phase 3
Study type: Interventional

This is an open-label extension study of another study protocol, MCS-2-TWN-a. Subjects who have completed the 12-week treatment and procedures under the protocol MCS-2-TWN-a will be eligible for this study.

NCT ID: NCT01002222 Completed - Clinical trials for Benign Prostatic Hyperplasia

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)

MCS-2-US-c
Start date: January 2011
Phase: Phase 3
Study type: Interventional

This is an open-label extension study of another study protocol, MCS-2-US-a. Subjects who have completed the 12-week treatment and procedures under the protocol MCS-2-US-a will be eligible for this study.

NCT ID: NCT00947882 Completed - Clinical trials for Lower Urinary Tract Symptoms (LUTS)

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

DELUTS
Start date: August 2009
Phase: Phase 2
Study type: Interventional

A dose-finding, multi-centre, double-blind, randomised, parallel, placebo-controlled trial to investigate efficacy and safety of degarelix in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

NCT ID: NCT00939120 Completed - Clinical trials for Benign Prostatic Hyperplasia (BPH)

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)

LUTS
Start date: July 2009
Phase: Phase 4
Study type: Interventional

This is an investigator-initiated study of safety, efficacy and tolerability of dutasteride given for 18 months, including a 1-year double-blind randomized co-administration with either tolterodine ER or placebo in men suffering from lower urinary tract symptoms (LUTS) including urgency and frequency, with or without urgency urinary incontinence (i.e., overactive bladder (OAB) symptoms).

NCT ID: NCT00918034 Completed - Clinical trials for Benign Prostatic Hyperplasia

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Start date: May 2009
Phase: Phase 2
Study type: Interventional

This is a phase 2 study to evaluate the safety and effectiveness of light-activated talaporfin sodium in patients with LUTS due to benign prostatic hyperplasia (BPH).

NCT ID: NCT00908427 Completed - Clinical trials for Benign Prostatic Hyperplasia

Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia

Start date: June 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to compared the efficacy of 80W KTP photoselective laser vaporization prostatectomy (PVP) and transurethral resection of the prostate (TURP) in reducing the volume of prostate and relieving the obstruction in men with benign prostatic hyperplasia (BPH) on non-randomized controlled design.